These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


80 related items for PubMed ID: 6380382

  • 21. [Evaluation of captopril levels in chronic congestive heart failure, stages NYHA III and IV].
    Mazur-Cichocka M, Michałowicz B, Stasiński T, Wierzchowiecki M.
    Pol Tyg Lek; ; 46(19-21):375-9. PubMed ID: 1845677
    [Abstract] [Full Text] [Related]

  • 22. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L, Apostolou T, Bonoris P, Foussas S, Lefkos N, Zombolos S.
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [Abstract] [Full Text] [Related]

  • 23. [Precapillary pulmonary hypertension: effect of Captopril].
    Sanguinetti M, Galiè N, Magelli C, Orselli L, Magnani B.
    G Ital Cardiol; 1982; 12(6):436-41. PubMed ID: 6761221
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of chronic cardiac failure with cadralazine. Short- and medium-term results].
    Gibelin P, Lloret JL, Drici M, Leborgne L, Camous JP, Mélia P, Morand P.
    Arch Mal Coeur Vaiss; 1987 Feb; 80(2):199-205. PubMed ID: 3107506
    [Abstract] [Full Text] [Related]

  • 25. [Acute hemodynamic effects of nicardipine in patients with chronic congestive heart failure].
    Tondi S, Zennaro RG, Masciocco L, Mattioli G.
    Cardiologia; 1989 Dec; 34(12):1013-9. PubMed ID: 2634477
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M, Lunati M, Gasparini M, Santini M, Padeletti L, Achilli A, Bianchi S, Laurenzi F, Curnis A, Vincenti A, Valsecchi S, Denaro A, InSync/InSync ICD Italian Registry Investigators.
    Am J Cardiol; 2007 Sep 15; 100(6):1007-12. PubMed ID: 17826388
    [Abstract] [Full Text] [Related]

  • 27. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
    Just H, Drexler H, Taylor SH, Siegrist J, Schulgen G, Schumacher M.
    Herz; 1993 Dec 15; 18 Suppl 1():436-43. PubMed ID: 8125424
    [Abstract] [Full Text] [Related]

  • 28. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.
    Am Heart J; 2003 Mar 15; 145(3):459-66. PubMed ID: 12660669
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Hemodynamics and clinical data in chronic coronary disease with severe left ventricular systolic dysfunction].
    Marinato PG, Dametto E, Maragno I, Razzolini R, Chinellato P, Santostasi G, Dalla Volta S.
    Cardiologia; 1996 Apr 15; 41(4):349-59. PubMed ID: 8674104
    [Abstract] [Full Text] [Related]

  • 31. Vasodilator therapy in children: acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation.
    Beekman RH, Rocchini AP, Dick M, Crowley DC, Rosenthal A.
    Pediatrics; 1984 Jan 15; 73(1):43-51. PubMed ID: 6361679
    [Abstract] [Full Text] [Related]

  • 32. Importance of venodilation during long-term vasodilator therapy of chronic left ventricular failure.
    Franciosa JA, Leddy CL, Schwartz DE.
    Z Kardiol; 1983 Jan 15; 72 Suppl 3():168-72. PubMed ID: 6666217
    [Abstract] [Full Text] [Related]

  • 33. [Effect of treatment with vasodilators on physical exercise tolerance in patients with chronic congestive heart failure].
    Markiewicz K, Górski L, Broks-Bratkowska B, Cholewa M.
    Pol Tyg Lek; 1983 Jan 15; 48(3-4):61-4. PubMed ID: 8361890
    [Abstract] [Full Text] [Related]

  • 34. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov 15; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B, Holmer SR, Hengstenberg C, Lieb W, Pfeifer M, Schunkert H.
    Int J Cardiol; 2005 Aug 18; 103(2):182-6. PubMed ID: 16080978
    [Abstract] [Full Text] [Related]

  • 40. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M, Brinkmann M, Freund U, Piotrowski J, Schieffer M, Velser U.
    Herz; 1995 Dec 18; 20(6):399-411. PubMed ID: 8582699
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.